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ABSTRACT
Increased thickness of the outer plexiform layer (OPL) of the fovea in central serous chorioretinopathy (CSC) has 
been previously reported. However, to our knowledge only one paper has given a concrete value of the thickness of the 
outer plexiform layer (OPL) of the macula in a patient with unilateral CSC. Here we report the outer plexiform and 
outer nuclear layer (ONL) thickness as measured with spectral domain optical coherence tomography (SD-OCT)  
in a patient with acute central serous chorioretinopathy in the left eye, and in a second patient with recurrent central 
serous chorioretinopathy in both eyes. Both patients received oral eplerenone treatment.
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CASE HISTORY
A 41-year-old male patient (KP) was referred to 
the Department of Ophthalmology of the Pomera-
nian Medical University in 2011. His uncorrected 
visual acuity (UCVA) was 0.6 in the right eye and 
0.1 in the left eye. His medical history was unre-
markable. Based on time domain optical coherence 
tomography and intravenous fluorescein angiog-
raphy the patient was diagnosed with CSC in the 
left eye. The patient was observed for three months 
during which spontaneous subretinal fluid reab-
sorption occurred. Recurrence of his condition hap-
pened after four years. Once again he was referred to 
the Department of Ophthalmology of the Pomer-
anian Medical University. He was re-evaluated and 
enrolled for oral eplerenone therapy. Best corrected 
visual acuity (BCVA) in both his right and left eye 
was 1.0. SD-OCT was performed using Heidelberg 
Spectralis HRA + OCT in 30º ART + EDI mode. 
A total of 25 scans of both the right and left macula 
were taken during both examinations. The bound-
aries of every layer of the macula in each scan were 
defined manually. Layer thickness was calculated by 
Heidelberg Eye Explorer software in nine subfields 
of the standard ETDRS grid. The values of the 
OPL and ONL thickness prior to treatment and at 
follow-up are given in Table 1 and Figure 1. During 
follow-up on the second day of eplerenone treat-
ment spontaneous subretinal fluid reabsorption 
occurred and his OPL thickness decreased in the 
superior inner macula subfield (SIM), nasal inner 
macula subfield (NIM), inferior inner macula sub-
field (IIM), and temporal inferior macula subfield 
(TIM). The outer nuclear layer (ONL) also expe-
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rienced changes during treatment. In all but the 
superior outer macula subfield (SOM), nasal outer 
macula subfield (NOM), and inferior outer macula 
subfield (IOM) the thickness decreased slightly. In 
the remaining subfields an evident increase in thick-
ness occurred.
Our second patient, a 37-year-old male patient 
(MB), presented to the Department of Ophthal-
mology of the Pomeranian Medical University with 
subjective decreased visual acuity in the left eye last-
ing for three months. His medical history was un-
remarkable. At presentation his uncorrected visual 
acuity (UCVA) was 1.0 both in the right and left 
eye. Intravenous fluorescein angiography disclosed 
a serous retinal detachment in the macula of the 
left eye, which was proven on SD-OCT. Based on 
these findings the patient was diagnosed with CSC 
in the left eye and qualified for treatment with oral 
eplerenone. SD-OCT using a Heidelberg Spectralis 
HRA + OCT in 30º ART + EDI mode was per-
formed on day 12 after initiation of treatment and 
on day 32. A total of 25 scans of the right and left 
macula were taken during both examinations. The 
boundaries of every layer of the macula in each scan 
were defined manually. Layer thickness was calcu-
lated by Heidelberg Eye Explorer software in nine 
subfields of the standard ETDRS grid. The results 
of both OPL and ONL during both visits are given 
in Table 2 and Figure 2. On day 12 after initiation 
of treatment the subretinal fluid was absorbed and 
reappeared on day 32. At this time, OPL thickness 
increased in all but the nasal outer macula subfield 
(NOM), inferior inner macula subfield (IIM), inferi-
or outer macula subfield (IOM), and temporal outer 
macula subfield (TOM). ONL thickness remained 
stable in superior outer macula (SOM) and temporal 
outer macula (TOM) subfields, decreased in supe-
rior inferior macula (SIM), nasal inferior macula 
Table 1. Outer plexiform layer and outer nuclear layer thickness of the left eye of patient KP during the 
examination before treatment and after day 2 of treatment. All values are given in μm
OPL/ONL thickness in subfields SIM SOM NIM NOM IIM IOM TIM TOM
Examination before treatment 48/64 29/70 37/51 27/63 42/43 26/61 57/49 33/60
Examination at day 2 40/73 30/69 33/62 29/61 34/53 26/60 40/70 32/62
SIM — superior inferior macula; SOM — superior outer macula; NIM — nasal inferior macula; NOM — nasal outer macula; IIM — inferior inner macula; IOM — inferior outer macula; 
TIM — temporal inferior macula; TOM — temporal outer macula 
FIGURE 1. The values of the OPL and ONL thickness prior to treatment and at follow-up in patient KP
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flectivity at the level of the outer nuclear layer and 
outer plexiform layer in 16 out of 18 patients with 
CSC, attributing this to probable accumulation 
of subretinal fluid within these layers [3]. Simi-
lar hyper-reflectivity on SD-OCT was observed by 
Ouyang et al. in a 49-year-old patient with unilat-
eral CSC, believing it to be caused by slight tilting 
during scan acquisition [4]. Moreover, Plateroti et 
al. have described intraretinal deposits within the 
outer plexiform layer visible on SD-OCT in 7 out 
of 13 patients examined, with acute CSC appearing 
at different times in the course of the disease [5]. 
In our opinion the hyper-reflectivity of the OPL 
causing the observed increased outer plexiform layer 
thickness as detected in SD-OCT in our CSC pa-
tients represents backscatter of reflected light from 
the Henle fibre layer, which is disfigured by the 
underlying subretinal fluid [6]. We speculate that 
macular pigment released in CSC from the Henle 
(NIM), inferior outer macula (IOM), and temporal 
inferior macula (TIM) subfields, and increased in 
nasal outer macula (NOM), inferior inner macula 
(IIM), and inferior outer macula (IOM) subfields.
DISCUSSION
Central serous chorioretinopathy is a common 
disorder involving detachment of the neurosen-
sory retina and/ or pigmented epithelium due to 
subretinal fluid accumulation and choroidal vessel 
hiperpermeability [1]. It has been associated with 
a number of conditions such as collagen vascular 
diseases, IBD, endogenous hypercorticolism (Cush-
ing disease) and factors such as type A personality, 
exogenous corticosteroid use, antihistamine use [2].
Recent studies using SD-OCT on patients with 
CSC have revealed different intraretinal abnormal-
ities. Ahlers et al. demonstrated diffuse hyper-re-
FIGURE 2. The values of the OPL and ONL thickness prior to treatment and at follow-up in patient MB
Table 2. Outer plexiform layer and outer nuclear layer thickness of the left eye of patient MB during 
examination on day 12 and 32. All values are given in μm
OPL/ONL thickness in subfields SIM SOM NIM NOM IIM IOM TIM TOM
Examination at day 12 29/80 25/72 37/68 27/67 29/66 27/58 26/64 27/68
Examination at day 32 36/73 27/72 39/66 25/69 28/67 25/61 34/55 26/68
SIM — superior inferior macula; SOM — superior outer macula; NIM — nasal inferior macula; NOM — nasal outer macula; IIM — inferior inner macula; IOM — inferior outer macula; 
TIM — temporal inferior macula; TOM — temporal outer macula 
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fibre layer could also have an influence on the hy-
per-reflectivity of the outer plexiform layer as ob-
served in SD-OCT by minimising the amount of 
scattered light; the light backscatter from the Henle 
fibres could then be better detectable. Macular pig-
ment has been noted to be released from the Henle 
fibre layer and inner plexiform layer in patients with 
both acute and chronic CSC [7]. Further studies 
to evaluate the potential role of macular pigment 
of the hyper-reflectivity of the OPL are warranted. 
Interestingly, we also observed changes in the thick-
ness of the outer nuclear layer above areas of subreti-
nal fluid. The thickness of this layer decreased, while 
the thickness of the outer plexiform layer increased. 
The opposite happened in the case of reabsorption 
of subretinal fluid.
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